Clinical reactivity to ingestion challenge with mixed mold extract may be enhanced in subjects sensitized to molds.
Manifestations of mold allergy are classically associated with inhalation of mold spores leading to symptoms of asthma and other respiratory illnesses. It is largely unknown, however, whether ingestion of aeroallergenic molds, mold spores, or other fungi found in food can also elicit hypersensitivity reactions in mold-sensitive individuals. The aim of this study was to evaluate the association between exposure to molds by oral challenge and elicitation of symptoms in mold- versus nonmold-sensitive individuals. Thirty-four adult atopic subjects were randomized into mold-sensitive groups based on skin test reactivity by skin percutaneous testing (SPT) and/or intradermal (ID) testing to a mixed mold (MM) extract preparation. All subjects underwent a single-blinded, placebo-controlled food challenge to the MM preparation. A modified scoring system was used to grade the clinical severity of symptoms elicited by challenge. All subjects tolerated challenges to the maximal oral mold dose concentration. However, higher symptom scores after challenge were found in mold-sensitive subjects compared with nonmold-sensitive subjects (p = 0.01). When mold-sensitive subjects were compared based on SPT and/or ID reactivity, higher symptom scores and lower symptom-eliciting concentrations of mold were associated with the SPT reactive subgroup compared with the subgroup with ID reactivity alone. In summary, based on our challenge results and scoring model, mold-sensitive subjects compared with nonmold-sensitive subjects experienced cumulatively higher symptom scores after oral challenge to an MM extract preparation. Future studies are warranted to confirm whether ingestion of aeroallergenic molds in food may be another contributor to symptoms in mold-sensitive individuals.
Luccioli
Stefano
S
International Center for Interdisciplinary Studies of Immunology, National Jewish Health, Denver, Colorado, USA.
Malka-Rais
Jonathan
J
Nsouli
Talal M
TM
Bellanti
Joseph A
JA
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000009:adverse effects / Q000276:immunology; D000946:Antigens, Fungal / Q000008:administration & dosage* / Q000276:immunology; D002457:Cell Extracts / Q000008:administration & dosage* / Q000276:immunology; D003429:Cross Reactions; D018450:Disease Progression; D004435:Eating; D005260:Female; D005658:Fungi / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology; D007114:Immunization; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
D000485:Allergens; D000946:Antigens, Fungal; D002457:Cell Extracts